Presenilin 1 Negatively Regulates β-Catenin/T Cell Factor/Lymphoid Enhancer Factor-1 Signaling Independently of β-Amyloid Precursor Protein and Notch Processing by Soriano, Salvador et al.
 
ã
 
 The Rockefeller University Press, 0021-9525/2001/02/785/10 $5.00
The Journal of Cell Biology, Volume 152, Number 4, February 19, 2001 785–794
http://www.jcb.org/cgi/content/full/152/4/785 785
 
Presenilin 1 Negatively Regulates 
 
b
 
-Catenin/T Cell Factor/Lymphoid 
Enhancer Factor-1 Signaling Independently of 
 
b
 
-Amyloid Precursor 
Protein and Notch Processing
 
Salvador Soriano,* David E. Kang,* Maofu Fu,
 
‡
 
 Richard Pestell,
 
‡
 
 Nathalie Chevallier,* Hui Zheng,
 
§
 
and Edward H. Koo*
 
*Department of Neurosciences, University of California, San Diego, La Jolla, California 92093; 
 
‡
 
The Albert Einstein Cancer Center, 
Department of Developmental and Molecular Biology, Albert Einstein College of Medicine, Bronx, New York 10461; and 
 
§
 
Hufﬁngton Center on Aging and Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas 77030
 
Abstract. 
 
In addition to its documented role in the pro-
 
teolytic processing of Notch-1 and the 
 
b
 
-amyloid pre-
cursor protein, presenilin 1 (PS1) associates with 
 
b
 
-cate-
nin. In this study, we show that this interaction plays a
critical role in regulating 
 
b
 
-catenin/T Cell Factor/Lym-
phoid Enhancer Factor-1 (LEF) signaling. PS1 deﬁ-
ciency results in accumulation of cytosolic 
 
b
 
-catenin,
leading to a 
 
b
 
-catenin/LEF-dependent increase in cyclin
D1 transcription and accelerated entry into the S phase
of the cell cycle. Conversely, PS1 speciﬁcally represses
LEF-dependent transcription in a dose-dependent man-
ner. The hyperproliferative response can be reversed by
reintroducing PS1 expression or overexpressing axin,
but not a PS1 mutant that does not bind 
 
b
 
-catenin
(PS1
 
D
 
cat) or by two different familial Alzheimer’s dis-
ease mutants. In contrast, PS1
 
D
 
cat restores Notch-1
proteolytic cleavage and A
 
b
 
 generation in PS1-deﬁcient
cells, indicating that PS1 function in modulating 
 
b
 
-cate-
nin levels can be separated from its roles in facilitating
 
g
 
-secretase cleavage of 
 
b
 
-amyloid precursor protein
and in Notch-1 signaling. Finally, we show an altered re-
sponse to Wnt signaling and impaired ubiquitination of
 
b
 
-catenin in the absence of PS1, a phenotype that may
account for the increased stability in PS1-deﬁcient cells.
Thus, PS1 adds to the molecules that are known to regu-
late the rapid turnover of 
 
b
 
-catenin.
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Introduction
 
Presenilin 1 (
 
PS1
 
)
 
1
 
 is the major gene responsible for famil-
ial Alzheimer’s disease (FAD).
 
 
 
Inherited mutations in 
 
PS1
 
cause an early-onset form of Alzheimer’s disease (AD)
with an autosomal-dominant pattern (Levy-Lahad et al.,
1995; Sherrington et al., 1995). PS1 is required for consti-
 
tutive proteolytic cleavage of the 
 
b
 
-amyloid precursor pro-
tein (APP) to generate amyloid 
 
b
 
-peptide (A
 
b
 
), while mu-
tations in 
 
PS1
 
 selectively increase the longer forms of A
 
b
 
(De Strooper et al., 1998; reviewed by Haass and De
Strooper, 1999). PS1 is a multiple-pass transmembrane
protein localized mainly to the endoplasmic reticulum and
Golgi membranes in nonneuronal cells as well as in cell
bodies and dendrites in neurons (Cook et al., 1996; An-
naert et al., 1999), and is expressed in all tissues examined
(Doan et al., 1996; Kovacs et al., 1996; De Strooper et al.,
1997; Lehmann et al., 1997; Li et al., 1997). Recent studies
have also shown that PS1 interacts with calsenilin (Bux-
 
baum et al., 1998) and is present in cadherin/catenin
complexes and is localized in the intercellular contacts
(Georgakopoulos et al., 1999). Full-length PS1 undergoes
constitutive endoproteolytic processing to generate an
 
amino-terminal fragment of 
 
z
 
28 kD and a carboxy-termi-
nal fragment of 
 
z
 
17 kD that remain stable as part of the
same complex (Thinakaran et al., 1996a; Zhang et al.,
1998b). PS1 null mice die late in embryonic development
or shortly after birth, exhibiting cerebral hemorrhages and
abnormal patterning of the axial skeleton and spinal gan-
glia (Shen et al., 1997; Wong et al., 1997). In 
 
Caenorhabdi-
tis elegans
 
, the PS1 homologue Sel-12 functions to facili-
tate Lin-12/Notch signaling (Levitan and Greenwald,
1995). Recent reports provided convincing evidence that
this activity is highly conserved. Specifically, there is an
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absolute requirement for PS1 in the proteolysis of the
Notch transmembrane domain after ligand binding with
consequent release of the Notch intracellular domain
(NICD), which translocates into the nucleus (De Strooper
et al., 1999; Struhl and Greenwald, 1999; Ye et al., 1999).
PS1 has been shown to interact with 
 
b
 
-catenin and this
association has been implicated in modulating the Wnt-
 
b
 
-catenin signaling pathway (Zhou et al., 1997; Murayama
et al., 1998; Yu et al., 1998; Kang et al., 1999; Stahl et al.,
1999). Wnt proteins represent a family of developmentally
important signaling molecules, at the heart of which is the
regulation of the cytosolic pool of 
 
b
 
-catenin (reviewed in
Willert and Nusse, 1998). In the absence of Wnt, cytosolic
 
b
 
-catenin is rapidly turned over by the proteasome, in a
pathway requiring phosphorylation by glycogen synthase
kinase-3
 
b
 
 (GSK-3
 
b
 
) and ubiquitination. Adenomatous
polyposis coli (APC) and axin combine to positively mod-
ulate GSK-3
 
b
 
 activity and promote 
 
b
 
-catenin degradation
(Hart et al., 1998; Ikeda et al., 1998). Binding of Wnt
ligands to cell surface receptors triggers a pathway that an-
tagonizes 
 
b
 
-catenin degradation by inactivating GSK-3
 
b
 
,
leading to 
 
b
 
-catenin stabilization and subsequent translo-
cation to the nucleus. In the nucleus, 
 
b
 
-catenin binds to
the T cell factor/lymphoid enhancer factor-1 (LEF) family
of transcription factors and mediates transcriptional acti-
vation of downstream target genes (Behrens et al., 1996).
A number of genes have been shown to be activated by
the 
 
b
 
-catenin/LEF complex. The first two genes identified
were c-myc and cyclin D1 (He et al., 1998; Shtutman et al.,
1999; Tetsu and McCormick, 1999). The cyclin D1 gene
encodes the regulatory subunit of the holoenzyme that
phosphorylates and inactivates the Rb tumor suppressor
protein. Transcriptional induction of the cyclin D1 gene by
several oncogenes (Ras, Src, Erb-B2, Rac; reviewed in
Sherr, 1996) contributes to the increased abundance of cy-
clin D1 protein. A requirement of cyclin D1 in G1 phase
progression induced by a variety of mitogens and onco-
genes has been established. Fibroblasts derived from mice
with the cyclin D1 gene deleted have reduced proliferative
capacity and increased apoptosis, suggesting a critical role
for cyclin D1 in cellular proliferation and survival (Brown
et al., 1998; Albanese et al., 1999).
Although PS1 appears to modulate 
 
b
 
-catenin stability in
vitro, controversial data have been reported. While we
and Murayama et al. (1998), showed that wild-type PS1
negatively regulates 
 
b
 
-catenin stability (Kang et al., 1999),
others (Zhou et al., 1997; Weihl et al., 1999) have pre-
sented evidence that wild-type PS1 stabilized 
 
b
 
-catenin.
Thus, the recent discovery that cyclin D1 is activated by
LEF signaling provided the opportunity to test our hy-
pothesis that PS1 is a negative regulator of 
 
b
 
-catenin sta-
bility. In the present study, we showed that PS1 indeed fa-
cilitates the rapid turnover of 
 
b
 
-catenin. In PS1 null cells,
we found increased 
 
b
 
-catenin stability, higher cyclin D1
protein levels, and increased rate of G1-to-S phase pro-
gression in the cell cycle. The hyperproliferative response
can be reversed by reintroducing PS1 expression or over-
expressing axin, but not by PS1 forms lacking the 
 
b
 
-cate-
nin binding site or harboring FAD mutations, and is inde-
pendent of Notch-1 signaling and A
 
b
 
 generation. Finally,
we show an altered response to Wnt signaling and im-
paired ubiquitination of 
 
b
 
-catenin in the absence of PS1,
 
offering a potential mechanism as to where PS1 facilitates
 
b
 
-catenin turnover.
 
Materials and Methods
 
Antibodies
 
PS1 polyclonal antibodies J27 (against residues 27–42), PS1NT (1–65),
 
a
 
PS1Loop (against residues 319–442), and monoclonal antibody PSN2
(against residues 31–56) have been described (Thinakaran et al., 1996b,
1998; Zhang et al., 1998b; Kang et al., 1999). APP antibodies 3134,
26D6, and CT15 have been described (Soriano et al., 1999; Lu et al.,
2000). Polyclonal antibody against c-myc was from BabCO. Other mono-
clonal antibodies used were against 
 
b
 
-catenin (Transduction Laborato-
ries and Sigma-Aldrich), ubiquitin, cyclin D1, cyclin A, and Cdc2 (Cal-
biochem), 
 
b
 
-tubulin (Amersham Pharmacia Biotech) and 9E10, against
c-myc (DSHB), used against c-myc–tagged 
 
D
 
EMV and ICV Notch-1
proteins.
 
cDNA Constructs
 
A cDNA encoding the wild-type PS1 sequence lacking amino acids 330–
360 (PS1
 
D
 
cat) was generated by PCR-mediated deletion and confirmed
by sequencing. Wild-type PS1, PS1
 
D
 
cat, and axin (a gift of Frank Costan-
tini, Columbia University, New York, NY) were subcloned into pIND (In-
vitrogen) or pBabe-puro (Morgenstern and Land, 1990). The latter vector
was used to generate replication-incompetent retroviruses in GP
 
1
 
E-86
packaging cell line. Myc-tagged NH
 
2
 
-terminal truncated Notch-1 con-
struct (
 
D
 
EMV, in which methionine 1726 has been mutated to valine to
eliminate translation initiation at that site; described in Kopan et al., 1996)
and Notch-1 intracellular domain (ICV, in which valine 1744 is the first
amino acid after the initiating methionine) were provided by Dr. R. Ko-
pan (Washington University, St. Louis, MO). The former is an artificial
construct specifically designed to examine the transmembrane cleavage of
Notch-1 protein (Kopan et al., 1996). The human cyclin D1 promoter re-
porter constructs 
 
2
 
163CD1Luc, 
 
2
 
163
 
D
 
lefCD1Luc, 
 
2
 
1745CD1Luc, as
well as the PALUC reporter, which contains 7 kb of the human cyclin A
promoter and the cyclin E promoter were previously described (Shtutman
et al., 1999).
 
Cell Lines
 
PS1
 
2
 
/
 
2
 
 and PS1
 
1
 
/
 
2
 
 fibroblasts were prepared from whole embryos at
embryonic day 15.5. Head and liver were discarded and the bodies were
triturated in 5 ml of a 0.25% trypsin/PBS solution and incubated at 37
 
8
 
C
for 15 min with continuous rotation. Tissue debris was allowed to settle at
4
 
8
 
C and supernatant with cells was transferred to a new tube. Fresh
trypsin was added to the remaining tissue and the process was repeated a
total of three times. Cells from all incubations were pooled, spun at 200 
 
g,
 
and resuspended in RPMI medium containing 10% FCS. Cells were
plated onto 25-cm
 
2
 
 flasks and allowed to reach confluence (usually 
 
z
 
16
h). Cells from early passages (between two and five) were used in all ex-
periments. To generate primary fibroblasts expressing wild-type PS1 or
PS1 lacking amino acids 330–360 (PS1
 
D
 
cat), early passage primary fibro-
blasts were infected with the corresponding retroviruses in the presence of
10 
 
m
 
g/ml polybrene for 8 h and allowed to grow to confluence without an-
tibiotic selection. Cells were then trypsinized and used directly for the in-
dicated experiments. Only cells passaged once after infection were used.
Expression levels of both wild-type PS1 and PS1
 
D
 
cat in PS1
 
2
 
/
 
2
 
 cells
were detected by Western blotting and were comparable with those in
PS1
 
1
 
/
 
2
 
 cells. Immortalized fibroblasts (used in Notch-1 transfections and
transcriptional activation studies), and EcR293 cells inducibly expressing
wild-type PS1 and PS1
 
D
 
cat have been described (Kang et al., 1999; Sori-
ano et al., 2001).
 
Immunoprecipitation and Western Blotting
 
Cultured cells were lysed in 1% 3-[(3-cholamidopropyl) dimethylammo-
nio]-2-hydroxy-1-propanesulfonate (CHAPS) buffer containing 50 mM
Tris, 150 mM NaCl, 100 
 
m
 
g/ml amino ethyl benzenesulfonyl fluoride
(AEBSF), and 10 
 
m
 
g/ml leupeptin on ice for 20 min. Lysates were pre-
cleared with normal rabbit serum and protein A agarose (for rabbit poly-
clonal antibodies) or with anti–mouse IgG agarose (for mouse mono-
clonal antibodies). Cleared lysates were then incubated with primary 
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antibody and protein A agarose or anti–mouse IgG agarose for 3 h at 4
 
8
 
C
as described (Kang et al., 1999). Immunoprecipitates were washed twice
with CHAPS buffer, and proteins were separated on SDS-PAGE and
transferred to nitrocellulose membranes. Coimmunoprecipitated proteins
were detected by Western blotting as above.
 
Turnover of Cytosolic 
 
b
 
-Catenin
 
Overnight cultures of embryonic fibroblasts from six-well tissue culture
plates were incubated in methionine-free medium for 20 min, followed by
metabolic labeling with 200 
 
m
 
Ci/ml [
 
35
 
S]methionine for 20 min and chas-
ing for the indicated periods. At each time point, cells were placed on ice
and washed twice with ice-cold PBS. To release cytosolic proteins, cells
were incubated twice for 10 min with 0.1% saponin buffer containing 25
mM Hepes and 75 mM potassium acetate. The two soluble fractions were
pooled and 
 
b
 
-catenin immunoprecipitated with a 
 
b
 
-catenin monoclonal
antibody. Immunoprecipitates were washed twice with buffer containing
50 mM Tris, 150 mM NaCl, and 1% NP-40 and proteins separated by stan-
dard SDS-PAGE. Dried gels were either exposed to film or quantitated
by phosphorimaging (Bio-Rad Laboratories). All experiments were per-
formed at least three times and results from either a representative exper-
iment or averages 
 
6
 
 SD are shown.
 
Transient Reporter Assays
 
Reporter gene assays in PS1
 
2
 
/
 
2
 
 and 
 
1
 
/
 
2
 
 were performed with the Dual-
luciferase reporter assay system (Promega) following the manufacturer’s
instructions after transfection with 
 
2
 
163CD1 and 
 
2
 
163
 
D
 
LefCD1 reporter
constructs (Shtutman et al., 1999). 50 ng pRL-TK renilla luciferase were
cotransfected in each sample as an internal control for transfection effi-
ciency. Results are expressed as an average of three independent experi-
ments performed in triplicate. In experiments with 293 cells, transient
transfection of cyclin D1, cyclin A, and cyclin E promoter constructs was
carried out with calcium phosphate precipitation for 6 h. 24 h later, lu-
ciferase activity was determined by comparison with that of an equal
amount of empty vector (Albanese et al., 1999). Results are expressed as
mean 
 
6 
 
SEM of seven separate transfections.
 
Reverse Transcritption PCR
 
Total RNA was extracted with Trizol (Life Technologies). Reverse Tran-
scription (RT) PCR (25 ng total RNA/reaction) was performed using Su-
perscript II RNase H
 
2
 
Reverse Transcriptase (Life Technologies) to syn-
thesize first-strand cDNA and Taq DNA polymerase (Promega) for PCR
reactions. Semi-quantitative PCR was carried out in which the number of
cycles produced amplified products of 
 
b
 
-catenin, cyclin, and actin cDNAs
within a linear range. The optimized cycle profile for cyclin D1 was: 1 cycle,
94
 
8
 
C, 3 min; 24 cycles, 94
 
8
 
C, 1 h; 55
 
8
 
C, 45 min; 72
 
8
 
C, 1 h.
 
BrdU Staining
Primary fibroblasts from embryonic day 15.5 embryos were cultured on
glass coverslips overnight and incubated with BrdU for 45 min at 378C and
fixed and stained for BrdU incorporation using the BrdU labeling and de-
tection kit I (Boehringer) according to the manufacturer’s instructions.
Nuclei were counterstained with propidium iodide to assay for total cell
numbers.
APP Processing in Mouse Embryonic Fibroblasts
APP COOH-terminal fragments were identified in PS1 null cells infected
with retroviruses containing PS1 wild-type or PS1Dcat sequences using an-
tibody CT15. Ab secretion was analyzed by immunoprecipitation of con-
ditioned media using antibody 3134 followed by immunoblotting with
26D6.
Wnt Stimulation, b-Catenin Phosphorylation and 
Ubiquitination Studies
Previously described Wnt3a-transfected L cells (Shibamoto et al., 1998)
were used as a source of Wnt-3a–conditioned medium. Cells were Wnt-
stimulated for 2 h and washed extensively, and fresh medium was added
for 2.5, 5, and 7.5 h. Levels of cytosolic b-catenin were determined as de-
scribed above. In experiments where the phosphorylation state of axin
was analyzed, cells were lysed in NP-40 in the presence of phosphatase in-
hibitors (0.4 mM microcystin-LR, 1 mM vanadate, 50 mM NaF) through-
out the experiment, and axin bands were detected with an anti–axin anti-
serum, previously described by Willert et al. (1999). For in vivo
phosphorylation studies, cell monolayers z70% confluent (10-cm2 plates)
were treated with Wnt3a-CM or control medium. After 90 min, both me-
dia were aspirated and replaced with phosphate-free media with or with-
out Wnt3a-CM, together with 500 mCi/ml [32P] orthophosphate. After a
30-min incubation, media were aspirated and cells were washed once with
ice-cold PBS and lysed with NP-40 lysis buffer (1% NP-40, 150 mM NaCl,
50 mM Tris, pH 8.0, 5 mg/ml leupeptin, 100 mg/ml AEBSF, 0.4 mM micro-
cystin-LR, 1 mM vanadate, and 50 mM sodium fluoride). Lysates were
precleared for 10 min at 10,000 g and supernatants were used for b-cate-
nin immunoprecipitation as described above. Radiolabeled b-catenin was
separated by SDS-PAGE and visualized by phosphorimager (Bio-Rad
Laboratories) or autoradiography.
For ubiquitination studies, cell monolayers at z70% confluence in six-
well plates were treated with 10 mM of the proteasome inhibitor MG-132
(Calbiochem). At the indicated time points, cells were lysed with NP-40
lysis buffer and accumulation of ubiquitinated b-catenin was analyzed di-
rectly by Western blot with an antibody against b-catenin or by immuno-
precipitation with the same antibody followed by Western blot with a
polyclonal anti–ubiquitin antibody.
Results
Enhanced b-Catenin/LEF-dependent Cyclin D1 
Transcription and Accelerated Cell Proliferation in PS1 
Null Primary Mouse Embryonic Fibroblasts
We previously reported that the turnover rate of b-catenin
in PS1-deficient immortalized fibroblasts was slower when
compared with hemizygous PS11/2 cells, resulting in
higher levels of cytosolic b-catenin (Kang et al., 1999). Ac-
cordingly, based on the recent finding that cyclin D1 tran-
scription is activated by b-catenin/LEF, we predicted com-
parable alterations in cyclin D1 transcription in primary
fibroblasts from early passages. Western blotting showed
that PS12/2 cells contained higher amounts of b-catenin
and cyclin D1 protein (Fig. 1 a). In contrast, levels of cdc2
and cyclin A, two other related genes not subject to
b-catenin–mediated transcription (Tetsu and McCor-
mick, 1999), were not elevated in PS12/2 cells. This was
confirmed by quantitative RT-PCR, which showed that
PS12/2 cells expressed z 2.5-fold higher levels of cyclin
D1 mRNA than that of PS11/2 controls (2.53 6 0.1,
mean  6 SD, n 5 3) while b-catenin mRNA levels were un-
changed (Fig. 1 b). Consistent with our previous report us-
ing immortalized PS1-deficient cell lines (Kang et al., 1999),
pulse-chase experiments in primary fibroblasts showed that
b-catenin turnover was reduced in PS12/2 cells (data not
shown, see Fig. 3). No difference in cyclin D1 turnover was
detected (Fig. 1 c), demonstrating that differences in cyclin
D1 levels occurred at the transcriptional level.
To determine whether higher levels of cyclin D1 re-
sulted in increased rate of entry into S phase in PS12/2 fi-
broblasts, we assayed BrdU incorporation in primary fi-
broblasts from PS11/2 and PS12/2 embryos. Indeed,
BrdU incorporation was approximately twofold higher in
PS12/2 than PS11/2 cells (Fig. 1 d). Therefore, PS1 defi-
ciency in mouse embryonic fibroblasts is accompanied by
increased levels of b-catenin and cyclin D1, and acceler-
ated cell proliferation.
The sequence 281 to 273 in the cyclin D1 promoter
contains a consensus LEF binding site and has been shown
to represent the main contributor to b-catenin transactiva-
tion (Shtutman et al., 1999; Tetsu and McCormick, 1999).
To confirm that elevation of cyclin D1 mRNA seen inThe Journal of Cell Biology, Volume 152, 2001 788
PS12/2 cells represents enhanced b-catenin–mediated
transcription, we used reporter constructs containing the
281 to 273 LEF binding site (2163CD1), or with the
LEF-binding domain deleted (2163CD1DLEF) (Shtut-
man et al., 1999) and determined the LEF-dependent tran-
scriptional activation of the cyclin D1 promoter by mea-
suring the reporter luciferase activity in PS11/2 and
PS12/2 cells. As seen in Fig. 1 e, luciferase activity de-
rived exclusively from the 281 to 273 LEF binding site
(2163 CD1 subtracts 2163 CD1DLEF) was threefold
higher in PS12/2 cells when compared with PS11/2 cells
(10.7 6 0.2 vs. 3.7 6 0.25, average 6 SD, n 5 3). These re-
sults demonstrated that higher levels of cytosolic b-catenin
in PS12/2 cells correlated with enhanced Lef-dependent
transcription of cyclin D1.
The preceding observations can be argued to suggest
that, in hyperproliferating PS1-deficient cells, cyclin D1
transcription would be augmented in parallel, as an
epiphenomenon of faster cell growth. Therefore, it is es-
sential to corroborate that PS1 expression can specifically
modulate cyclin D1 transcription. To determine whether
the cyclin D1 promoter was a target of PS1 repression, we
assessed transcriptional activity from luciferase reporter
constructs containing the sequences for cyclin D1, as well
as those of cyclin A (which, despite containing a putative
LEF-1 binding site, is not activated by b-catenin/Lef; Tetsu
and McCormick, 1999) and cyclin E (which lacks a LEF-1
consensus site) promoters in 293 cells. As shown in Fig. 2 a,
wild-type LEF (Topflash) reporter was repressed in a
dose-dependent manner by PS1. 21745 CD1Luc reporter
(wild-type cyclin D1 promoter), which was induced z10-
fold by b-catenin (Shtutman et al., 1999), was significantly
repressed by PS1. Repression of reporter activity by PS1
was maintained in the 2163 CD1Luc, which contains the
consensus LEF binding site. However, mutation or dele-
tion of the LEF site abolished repression (Fig. 2 b). Impor-
tantly, neither cyclin A nor E reporter activity was re-
pressed by PS1 (Fig. 2 c). These results provide strong
evidence in favor of the concept that the enhanced levels
of cyclin D1 seen in PS1-deficient fibroblasts originate, at
least in part, from dysregulation of b-catenin turnover and
subsequent elevation of b-catenin/Lef-mediated activity,
rather than constituting an epiphenomenon of faster cell
growth.
Modulation of b-Catenin Signaling by PS1 Requires the 
Interaction of both Proteins
Earlier studies indicated that PS1 interacts with b-catenin
through its hydrophilic cytoplasmic loop domain, although
the precise binding site has not been carefully mapped
(Zhou et al., 1997; Yu et al., 1998; Stahl et al., 1999). We
performed pull-down assays using glutathione-S-trans-
ferase–PS1 loop fusion proteins in cell homogenates and
confirmed that amino acids 330–360 within the loop of PS1
are required for its association with b-catenin (Saura et al.,
2000). Based on these data, we generated a PS1 deletion
mutant lacking residues 330–360 (PS1Dcat) to determine
whether the effects of PS1 on b-catenin signaling and cell
proliferation require the interaction between PS1 and
b-catenin. Using the previously described muristerone-
inducible EcR293 cells (Kang et al., 1999), we confirmed
Figure 1. (a) Immunoblot analy-
sis of b-catenin, cyclin D1, cyclin
A, and Cdc2 from PS11/2 and
2/2 cells. b-catenin and cyclin
D1 levels were elevated in PS1-
deficient cells. (b) PS1-deficient
cells showed higher levels of cy-
clin D1 mRNA. Semiquantita-
tive RT-PCR analysis of b-catenin, cyclin D1, and actin from
PS12/2 and 1/2 primary fibroblasts. 25 ng of total RNA-
derived cDNA were used for PCR reactions. Controls without
reverse transcriptase yielded no bands (not shown). Results from
a representative experiment are shown. (c) Loss of PS1 did not
affect the turnover rate of cyclin D1. The cells were labeled for 20
min and chased for 15, 30, and 60 min. (Middle) Because PS12/2
cells have higher constitutive levels of cyclin D1, a shorter film
exposure of the same autoradiogram that is comparable with that
seen in PS1/2 cells is shown. Quantitation from three indepen-
dent experiments is shown (Bottom). (d) BrdU incorporation in
PS11/2 and 2/2 cells. Primary fibroblasts from embryonic day
15.5 embryos were incubated with BrdU for 45 min at 378C and
BrdU incorporation was determined as described in Materials
and Methods. Results are shown as the proportion of total cells
(calculated from propidium iodide-stained nuclei) that were posi-
tive for BrdU staining, and represent the average of two indepen-
dent experiments, each performed in triplicate (1,000 cells from
at least 10 independent fields were scored for each sample). (e)
Enhanced  b-catenin/LEF-induced activation of the cyclin D1
promoter in PS1-deficient cells. PS11/2 and PS12/2 fibroblasts
were transfected with constructs containing luciferase reporter
driven by the cyclin D1 promoters. 1 mg of 2163CD1 (wild type)
or 2163DlefCD1 (lacking the main LEF binding sequence) were
used together with 50 ng of pRL-TK renilla luciferase construct
in each sample as an internal control for transcription efficiency.
Results are shown as the ratio of reporter luciferase to control re-
nilla luciferase and represent the mean 6 SD of three indepen-
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that induction of PS1Dcat resulted in the production of a
shortened full-length PS1Dcat that was processed into a
z28-kD amino-terminal fragment (NTF) indistinguish-
able from wild-type NTF and an z14-kD carboxy-termi-
nal fragment lacking amino acids 330–360. Immunoprecip-
itation experiments showed the lack of binding of PS1Dcat
to b-catenin (Soriano et al., 2001).
We next examined the consequences of PS1Dcat expres-
sion in PS12/2 primary fibroblasts after retroviral-medi-
ated infection. In PS1Dcat infected PS12/2 fibroblasts, the
NH2- and COOH-terminal fragments, but not full-length
PS1, were detected, and lack of binding of PS1Dcat to
b-catenin in these cells was confirmed (Fig. 3 a). Expression
of wild-type PS1 resulted in a reduction of cytosolic b-cate-
nin levels, whereas introducing PS1Dcat had no significant
effect (Fig. 3 b, top; tubulin levels are shown at bottom as
loading control). By pulse-chase paradigm, b-catenin turn-
over was increased in wild-type PS1-infected PS12/2 cells
as expected, but expressing PS1Dcat in PS12/2 cells did not
have a significant effect (Fig. 3 c). As predicted from our
earlier results, the recovery of b-catenin turnover in pri-
mary PS12/2 cells after reintroduction of wild-type PS1 re-
sulted in a concomitant decrease in BrdU incorporation
(and therefore in cell proliferation; Fig. 3 d). In marked con-
trast, entry into S phase in PS12/2 cells was not modified
by reintroducing PS1Dcat or vector control.
Axin, in association with APC and GSK-3b, regulates
b-catenin degradation. Thus, mutations in axin were recently
detected in hepatocellular carcinoma, and in these tumor
cells overexpression of wild-type axin was shown to de-
crease b-catenin levels and suppression of cell growth (Sa-
toh et al., 2000). Taking advantage of this observation, we
expressed axin in PS1-deficient fibroblasts to determine
whether the hyperproliferative effect can be blocked by
specific inhibition of the b-catenin signaling pathway. As
shown in Fig. 3, axin overexpression resulted in a decrease
of both b-catenin levels and cell proliferation in PS12/2
cells to a degree that was comparable with the expression
of wild-type PS1 (Fig. 3, b and d). These results argue
that upregulated b-catenin signaling plays a functional
role for the accelerated cell proliferation in the absence
of PS1.
Effects of PS1 FAD Mutations on b-Catenin Signaling
The effects of FAD mutations on b-catenin turnover have
also been controversial. We previously reported that, in
cultured cells and transgenic mice expressing FAD muta-
tions, turnover of endogenous b-catenin was delayed, sug-
gesting a partial loss of function (Kang et al., 1999). In
view of the preceding observations, we examined the lev-
els of cytosolic b-catenin levels and BrdU incorporation in
PS1 null cells expressing these FAD PS1 mutations. As
shown in Fig. 4 a, expression of PS1 M146L or PS1 DX9,
unlike wild-type PS1, failed to downregulate cytosolic
b-catenin levels. Consistent with this finding, BrdU incor-
poration in these cells remained unchanged as compared
with expression of wild-type PS1 (Fig. 4 b). Thus, FAD
mutations in PS1 resulted in a loss of function with respect
to its ability to modulate b-catenin turnover.
Both Wild-Type PS1 and PS1Dcat Restore Normal 
Proteolytic Cleavage of Notch-1 and
g-Secretase Activity
Recent reports have shown that PS1 plays a central role
in the proteolytic release of the NICD (De Strooper et al.,
1999; Struhl and Greenwald, 1999; Ye et al., 1999), the
signaling domain of the Notch-1 receptor that translo-
cates into the nucleus to activate transcription of down-
stream genes. In addition, the role of PS1 in Notch pro-
cessing can be separated from its role in the modulation
of  g-secretase activity (Kulic et al., 2000). Therefore,
while studies described above have provided compelling
evidence that one of the functions of PS1 is to regulate cy-
tosolic b-catenin turnover, a role that requires interaction
of both proteins, we cannot exclude the possibility that
the cellular consequences we have defined are due to
the concomitant impairment of Notch signaling and/or
g-secretase activity. To address this issue, we analyzed
Notch-1 and APP processing in PS1 null cells infected
with retroviruses expressing either wild-type PS1 or
PS1Dcat to determine whether PS1Dcat is capable of
restoring Notch-1 processing and Ab generation. In
PS12/2 fibroblasts, NICD was not cleaved from the
DEMV Notch construct (Myc-tagged NH2-terminal trun-
Figure 2. (a) PS1 represses transcrip-
tion from the LEF-binding sequence
linked to a minimal promoter (Top-
Flash) in a dose-dependent manner.
TopFlash luciferase reporter (1.2 mg)
was cotransfected in 293 cells with in-
creasing amounts of wild-type PS1
(150–1,200 ng). Transcriptional repres-
sion is shown by its comparison with the
effect on equal amounts of empty ex-
pression vector (arbitrarily assigned a
luciferase activity of 1). (b) The TCF
site in the cyclin D1 promoter is re-
quired for repression by PS1. Repres-
sion of the cyclin D1 promoter after
PS1 transfection (300 ng) was main-
tained when the sequences between
21745 to 2163 of the promoter were deleted. In contrast, deletion of the LEF binding site (2163CD1DLefLuc) completely abrogated PS1
repression. (c) PS1 specifically regulates transcription of cyclin D1. Wild-type cyclin D1 promoter (21745CD1) and 2163CD1, both con-
taining the main LEF-binding site, are inhibited by PS1 expression. In contrast, neither cyclin A nor E transcription is affected by PS1.The Journal of Cell Biology, Volume 152, 2001 790
cated Notch-1, in which methionine 1726 has been mu-
tated to valine to eliminate translation initiation at that
site; Kopan et al., 1996). However, in both PS1 wild-type
and PS1Dcat-infected PS12/2 cell lines, the NICD re-
lease from DEMV Notch was clearly restored (Fig. 5 a).
Consistent with this restoration of Notch cleavage, ex-
pression of both PS1 wild-type and PS1Dcat also restored
Ab secretion and normal turnover of APP COOH-termi-
nal fragments (Fig. 5 b). It is also noteworthy that a PS1
form lacking the entire cytosolic loop that does not bind
b-catenin also restores Notch-1 cleavage in PS1 null cells
(Saura et al., 2000), in agreement with the above results.
Thus, increased cytosolic b-catenin stability and down-
stream signaling in PS12/2 cells are not the consequences
of impaired Notch-1 signaling or g-secretase activity. By ex-
tension, the upregulation of cyclin D1 transcription and
enhanced cell proliferation in the PS12/2 cells is most
likely due to perturbed b-catenin signaling, rather than
impaired Notch-1 or APP signaling.
Abnormal Modulation of b-Catenin Levels by Wnt3a 
Signaling in the Absence of PS1
Because aberrant Wnt stimulation is believed to result in
tumorigenesis in several tissues (reviewed in Barker et al.,
2000), we asked whether loss of PS1 alters the response to
Wnt signaling. In primary mouse embryonic fibroblasts
with or without PS1, the levels of cytosolic b-catenin and
axin phosphorylation, parameters that have been shown to
be modulated by Wnt signaling (Willert et al., 1999, and
references therein) were determined after Wnt-3a stimula-
tion. Specifically, we examined axin phosphorylation and
b-catenin levels under the following conditions: (a) basal,
unstimulated state, (b) Wnt stimulation, and (c) after re-
moval of the Wnt signal. We chose these conditions be-
cause an adequate response to Wnt signaling in vivo in-
volves not only the adequate upregulation of b-catenin
levels and nuclear signaling after stimulation, but presum-
ably the timely restoration of basal levels once Wnt activa-
tion is switched off. As shown before, under basal condi-
tions, b-catenin levels were higher in the absence of PS1
(Fig. 6 a, lane 1, compare top and bottom). After treat-
ment with conditioned medium from Wnt-3a–transfected
cells (Wnt3a-CM) for 2 h, b-catenin increased substan-
tially in both PS11/2 and 2/2 cells, likely due to inactiva-
tion of GSK-3b (Fig. 6 a, lane 2). Concomitantly, there
was the appearance of a faint, faster migrating, dephos-
phorylated axin species (Fig. 6 b, lanes 2 and 3, arrow-
heads), consistent with dephosphorylated forms of axin, as
previously described (Willert et al., 1999). This species was
indistinguishable between PS11/2 and 2/2 cells, and was
no longer detectable 5 h after Wnt3a withdrawal (Fig. 6 b,
lane 4). In contrast, while cytosolic levels of b-catenin
were consistently restored in PS11/2 cells within 7.5 h af-
Figure 3. Effects of PS1 on b-catenin
stability and signaling require the in-
teraction of the two proteins. (a)
Expression of wild-type PS1 and
PS1Dcat were comparable in all ex-
periments, and similar to those in PS11/2 cells (not shown). As
DCTF lacks amino acids 330–360, a domain recognizable by the
aPS1Loop antibody, its signal appears to be weaker than wild-type
carboxy-terminal fragment. Immunoprecipitation with J27, an anti-
body against the NH2 terminus of PS1, shows that PS1Dcat does not
interact with b-catenin. (b, Top) Retroviral infection of wild-type
PS1 or axin, but not PS1Dcat, in PS1 null cells results in reduction of
cytosolic b-catenin levels. (Bottom) b-Tubulin blot shown as loading
control. (c) Expression of wild-type PS1 in PS1 null cells restores ef-
ficient degradation of b-catenin. In contrast, expression of PS1Dcat
has no significant effect. Cells were metabolically labeled with
[35S]methionine for 20 min, chased for 0, 10, and 30 min, and immu-
noprecipitated for cytosolic b-catenin as described in Materials and
Methods. Results from a representative experiment performed in
duplicate are shown. (d) Decrease in BrdU incorporation in
PS12/2 cells after expression of wild-type PS1 and axin, but not
PS1Dcat. Cells were infected with the indicated retroviral vectors,
and BrdU incorporation was performed as described 48 h after plat-
ing when the cells reached 70–80% of confluence.
Figure 4. (a, Top) Retroviral infection of wild-type PS1, but not
FAD mutants M146L and DX9, results in reduction of cytosolic
b-catenin levels. (Middle) b-Tubulin blot shown as loading con-
trol. A representative experiment is shown. (b) Decrease in
BrdU incorporation in primary PS1 null cells after expression of
wild-type PS1, but not FAD mutants M146L and DX9. Cells were
infected with the indicated retroviral vectors and BrdU incorpo-
ration was performed as described 48 h after plating, when the
cells reached 70–80% of confluence. Results from two indepen-
dent experiments performed in triplicate are shown.Soriano et al. Presenilin 1 in b-Catenin Signaling 791
ter Wnt3a withdrawal (Fig. 6 a, bottom, lane 5), b-catenin
levels remained consistently elevated at this same time
point in PS12/2 (Fig. 6 a, top, lane 5). Thus, our results
showed that, although Wnt stimulation properly elevates
b-catenin levels in PS1 null cells, the signal is abnormally
prolonged.
To determine which pool of cytosolic b-catenin was ab-
normally elevated in the absence of PS1, the levels of
phosphorylated  b-catenin were assessed in the presence or
absence of Wnt3a-CM. By labeling with 32P, the levels of
phosphorylated b-catenin were markedly elevated under
basal conditions in PS12/2 cells as compared with PS11/2
cells (Fig. 7 a, compare lane 1 with 3, top). After Wnt3a
stimulation, levels of phosphorylated b-catenin were
markedly reduced in both cell types (Fig. 7 a, top). The
rapid reduction in phosphorylated b-catenin levels, attrib-
utable to GSK-3b inactivation, indicated that, in response
to Wnt3a stimulation, this step of b-catenin dephosphory-
lation was unaffected by the absence of PS1.
In the current model of b-catenin degradation, phos-
phorylated  b-catenin should have been rapidly ubiquitinated
and degraded by the proteosome (Orford et al., 1997). The
accumulation of phosphorylated b-catenin suggested to us
that, in PS12/2 cells, b-catenin ubiquitination (i.e., down-
stream of phosphorylation) may be abnormal. Inhibition of
the proteasome results in the accumulation of the ubiquiti-
nated forms of proteins normally degraded by the ubiq-
uitin–proteasome pathway. Accordingly, high molecular
weight (HMW) b-catenin species containing ubiquitin ac-
cumulate after proteosome inhibition (Aberle et al., 1997;
Orford et al., 1997; Salomon et al., 1997). In PS11/2 con-
trol cells, HMW b-catenin species were detectable after 30
min of treatment with the proteosome inhibitor MG-132,
and further increased after 120 min (Fig. 7 b, bottom).
These HMW b-catenin bands were identical to the species
demonstrated to represent ubiquitinated b-catenin (Aberle
et al., 1997; Orford et al., 1997). In contrast, HMW forms of
b-catenin were apparent in PS1-deficient cells only after 60
min of treatment, and the overall response was blunted
even after 120 min (Fig. 7 b, top), suggesting that the ubiq-
uitinated b-catenin pool was diminished. Thus, higher lev-
els of phosphorylated b-catenin in PS1-deficient cells
apparently corresponded with delayed ubiquitination, co-
incidental with reduced degradation of b-catenin.
Discussion
In addition to its documented role in the proteolytic pro-
cessing of Notch and APP, PS1 has been shown to interact
with b-catenin. However, the biological consequences of
this latter interaction remain controversial. In the present
study, we provided evidence that loss of PS1 function re-
sults in increased stability of cytosolic b-catenin, leading
to enhanced b-catenin/Lef-dependent signaling, among
which is elevation of cyclin D1 levels. This, in turn, is asso-
ciated with increased entry into the cell cycle and cell pro-
liferation, a phenotype that can be reversed by expressing
wild-type PS1, but not a PS1 form that does not associate
with b-catenin. Conversely, overexpression of PS1 in vitro
results in LEF-mediated repression of cyclin D1 transcrip-
tion in a dose-dependent manner. All these effects on
b-catenin turnover by PS1 are independent of APP and
notch proteolysis and appear to be mediated at the level of
b-catenin phosphorylation/ubiquitination. Finally, FAD
mutations in PS1 cannot efficiently restore b-catenin deg-
radation in PS1 null primary fibroblasts.
Using primary mouse embryonic fibroblasts deficient in
PS1, we demonstrated that PS1 negatively modulates the
cytosolic (and hence signaling) pool of b-catenin. We
Figure 5. (a) PS1 null cells were
transfected with myc-tagged
DEMV (Notch lacking the extra-
cellular domain, in which inter-
nal methionine 1726 has been
changed to valine to eliminate
translation initiation at this site)
and ICV (intracellular domain of
Notch, in which valine 1744 is the
first amino acid after the initiating
methionine) constructs. 48 h after transfection, cells were lysed
and NICD release was analyzed by Western blotting. The
cleaved Notch-1 fragment is detected in cells expressing both
wild-type PS1 and PS1 deficient in b-catenin binding (PS1Dcat),
but not in PS12/2 cells. Results from a representative experi-
ment are shown. (b) PS12/2 cells were infected with retroviral
viruses containing APP (top), together with either PS1 wild type
or PS1Dcat sequences, and turnover of APP COOH-terminal
fragments (middle) and Ab secretion (bottom) were analyzed as
described in Materials and Methods. PS11/2 cells expressing
similar amounts of APP (top) are shown as a control.
Figure 6. (a) Abnormal
b-catenin turnover after Wnt
stimulation in the absence of
PS1. Primary PS12/2 and
PS11/2 fibroblasts were in-
cubated with Wnt-3a–condi-
tioned medium (Wnt-CM) as
described in Materials and
Methods. After 2 h of treat-
ment, Wnt-CM was re-
moved, and cells were washed
extensively and incubated for
the indicated time points with
fresh normal medium. Shown
are the levels of cytosolic
b-catenin. Results are repre-
sentative of three indepen-
dent experiments. (b) Cells
were treated with Wnt-CM
exactly as described for Fig. 5
a, and axin levels were ana-
lyzed by Western blot. Note
that the axin phosphorylation
pattern in response to Wnt is not different between PS11/2 and
2/2 cells. In marked contrast, restoration of b-catenin levels is de-
layed in PS12/2 cells with respect to control cells (a).The Journal of Cell Biology, Volume 152, 2001 792
showed that both cyclin D1 mRNA and protein were in-
creased in PS12/2 cells and this was correlated with
higher b-catenin/LEF–dependent transcriptional activity
from the cyclin D1 promoter in these cells. Moreover, we
observed that, as previously described for colon cancer
cells, increased levels of cyclin D1 in PS12/2 cells corre-
lated with accelerated progression through the G1 phase
of the cell cycle. It is important to note that increased cy-
clin D1 levels are unlikely to represent an epiphenomenon
of hyperproliferation in PS1 null cells. This is because PS1
expression can specifically modulate LEF-mediated tran-
scription in a dose-dependent manner, consistent with the
concept that increase in cyclin D1 levels occurs before hy-
perproliferation itself and as a consequence of PS1 defi-
ciency. In other words, we have provided compelling
evidence that PS1, through modulation of b-catenin sig-
naling, directly affects not only cyclin D1 levels, but also
cell growth associated with cyclin D1 activity. Finally, fur-
ther support of a direct causal effect rather than merely a
correlative link was demonstrated by using a mutant PS1
construct where the interaction between PS1 and b-cate-
nin was lost (Fig. 3). In short, accumulation of b-catenin
and increased cell proliferation in PS1-deficient cells can
be reversed by reintroducing wild-type PS1, but not
PS1Dcat, a PS1 mutant that does not bind b-catenin.
Our results also suggested a model in which PS1 func-
tions to regulate b-catenin turnover at a step after b-cate-
nin phosphorylation. In the absence of PS1, the rapid de-
phosphorylation of b-catenin after Wnt-3a stimulation was
retained. Moreover, modulation of axin phosphorylation
was also not altered during Wnt stimulation and with-
drawal in PS1-deficient cells. However, the elevation of
cytosolic b-catenin levels was seen both in basal (i.e., un-
stimulated) and after Wnt stimulation, and was accompa-
nied by an increase in the levels of phosphorylated b-cate-
nin. Thus, in the absence of PS1, turnover of b-catenin was
prolonged in both Wnt-3a–stimulated and at basal condi-
tions. Lastly, the increase in phosphorylated b-catenin,
which should normally be at very low levels due to rapid
degradation, was correlated with a decrease in ubiquiti-
nation. We therefore hypothesize that PS1 modulates
b-catenin degradation by facilitating ubiquitination. This
mechanism would be consistent with two recent reports
examining the interaction of Drosophila presenilin homo-
logue (DPS) and Armadillo/b-catenin (Arm/bcat). In
Drosophila, loss of endogenous DPS resulted in the accu-
mulation of Arm/b-cat in the cytoplasm (Noll et al., 2000),
leading the authors to suggest a possible role of DPS in
proteosomal degradation. In addition, in a genetic screen
of candidates that modify an Arm/bcat phenotype, DPS
was identified as a negative regulator of Wg/Wnt signaling
(Cox et al., 2000). Therefore, both of these findings in
Drosophila are entirely consistent with our present obser-
vations.
PS1 is required for the cleavage of Notch-1 to release
the signaling intracellular domain (NICD), a step neces-
sary for initiating downstream gene transcriptional activa-
tion (De Strooper et al., 1999; Struhl and Greenwald, 1999;
Ye et al., 1999). There is evidence to suggest that the
Notch and Wnt pathways are mutually inhibitory (Axel-
rod et al., 1996). Therefore, it can be argued that enhanced
b-catenin/LEF signaling and increased cell proliferation in
the absence of PS1 could be secondary to defective Notch
signaling. However, Notch-1 from PS12/2 cells express-
ing PS1Dcat is efficiently cleaved. The fact that this mutant
does not restore the b-catenin phenotype strongly suggests
that Notch-1 deficiency is not the cause of the abnormal
b-catenin phenotype. Thus, modulating b-catenin signal-
ing and facilitating Notch-1 proteolytic cleavage are likely
independent and parallel functions of PS1. It remains pos-
sible that the b-catenin activity facilitated by PS1 in vivo is
required at later stages of development and consequently
masked by its early requirement for Notch-1 signaling.
Consistent with the results on Notch-1 proteolysis, the
requirement of PS1 in g-secretase cleavage is independent
of b-catenin turnover. PS1Dcat also restores efficiently
g-secretase activity in PS12/2 cells, both in terms of APP
COOH-terminal fragments and Ab generation. These
findings, entirely consistent with the recent report of Saura
et al. (2000) again strongly suggest that this latter activity
and the role in b-catenin homeostasis are likely to be inde-
pendent functions of PS1. Thus, the association of PS1
with  b-catenin is not required in the intracellular compart-
ment where APP and Notch proteolysis takes place.
Taken together, our findings provide a parsimonious in-
terpretation that is consistent with the current model of
the Wnt–b-catenin pathway in which stabilization of b-cat-
enin, in this case through loss of PS1, leads to proliferative
signal via activation of cyclin D1. These results also argue
that the discrepant results reported by different laborato-
ries may reflect measurements of dissimilar pools of
b-catenin. While we examined the Wnt-3a–responsive
cytosolic pool of endogenous b-catenin defined as the
fraction that was saponin extractable, others assessed both
cytosolic and membrane-bound b-catenin expressed by
transient transfections (Zhang et al., 1998a). However, the
membrane-bound b-catenin pool is not responsive to Wnt
stimulation (data not shown). Furthermore, the presence
of lower molecular weight b-catenin species was used to
imply a stimulation of degradation without formal proof.
Although the identity and functional significance of these
species remain unknown, we suspect that they accumulate
Figure 7. (a, Top) Enhanced
phosphorylation of b-cate-
nin in PS1 null cells. Cells
were metabolically labeled
with  32P in the absence or
presence of Wnt3a-CM as
described in Materials and
Methods. Note the accu-
mulation of phosphorylated
b-catenin in PS1 null cells
both in basal conditions and
after Wnt stimulation. (Bot-
tom) Experiment performed
in parallel and identical to
the one described (top), ex-
cept that 32P labeling was
omitted. (b) Abnormal accu-
mulation of high molecular
weight species of b-catenin in PS1 null cells after proteasome in-
hibition. Cells were treated with MG-132 as described in Materi-
als and Methods and b-catenin accumulation was monitored at
the indicated time points.Soriano et al. Presenilin 1 in b-Catenin Signaling 793
when degradation of full-length b-catenin is defective (see,
for example, Schlosshauer et al., 2000). In short, these dis-
crepancies underscore the importance of defining accu-
rately the b-catenin pool under study, since its biological
role is tightly linked to its subcellular localization.
In our proposed scenario, the loss of PS1 would be simi-
lar to that postulated in a number of human cancers, in-
cluding colon, melanoma, hepatocarcinomas, and piloma-
tricomas of the skin. In these tumors, mutations in APC,
axin, or b-catenin result in abnormally high b-catenin lev-
els, and increased b-catenin/LEF signaling is thought to
contribute to neoplasic transformation (for reviews, see
Polakis, 1999; Roose and Clevers, 1999). In this respect, it
is of interest that epithelial hyperplasia and skin tumors
have been described in the majority of PS1 null mice res-
cued with the human PS1 transgene (hPS1) driven by the
neuronal-specific human Thy-1 (hThy) promoter (Zheng
et al., 2000). PS1 null mice die either embryonically or
perinatally. However, animals rescued by Thy-1–driven
hPS1 survive into adulthood. Since the skin of these ani-
mals has been shown to be deficient in PS1 and to show el-
evated b-catenin levels, the tumor phenotype in these res-
cue animals is consistent with constitutively upregulated
transcription of cyclin D1 in PS1-deficient skin, due to im-
paired attenuation of Wnt signals. However, a definitive
causal link between b-catenin levels, PS1 deficiency, and
tumor formation remains to be established.
In summary, our results demonstrated that PS1 is part of
the b-catenin degradation machinery, thereby adding PS1
to a list of known proteins that regulate b-catenin stability
(Orsulic and Peifer, 1996; Hart et al., 1998; Ikeda et al.,
1998; Seeling et al., 1999; Zorn et al., 1999). We propose a
model in which PS1 contributes to the rapid turnover of
b-catenin after its phosphorylation, possibly by some en-
hancement of the ubiquitination process. We have shown
that FAD mutations in PS1 represent a loss of its function
as a b-catenin modulator. Whether this phenotype con-
tributes to Alzheimer’s disease is an issue not addressed in
this study. Nevertheless, our results further emphasize the
importance of maintaining a rapid turnover of cytosolic
b-catenin in normal cell growth and differentiation.
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